Physician profile
Madelyn Kahn
NPI 1518428010
$830.88
in general payments reported to CMS, 2019-2025
12 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $325 · 2023: $69.09 · 2024: $182 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $325.00 | 2022 | |
| Astellas Pharma US INC | $125.72 | 2023-2025 | Veozah |
| Millicent US INC | $65.87 | 2025 | Femlyv, Intrarosa |
| Exeltis, USA INC. | $62.93 | 2024-2025 | Slynd |
| Mayne Pharma Commercial LLC | $51.45 | 2024-2025 | |
| Pfizer INC. | $46.34 | 2024-2025 | |
| Hologic Sales and Service, LLC | $42.77 | 2024-2025 | Myosure Tissue Removal Device, Acessa Provu System, Omni Hysteroscope |
| Abbvie INC. | $34.83 | 2024 | |
| Organon LLC | $21.87 | 2025 | Nexplanon |
| Ethicon US, LLC | $20.43 | 2023 | Harmonic |
| Biogen, INC. | $18.60 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $15.07 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madelyn Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.